Google to Unveil First Smartphone

Jacob Harper |

Since Google Inc. (GOOG) first announced they had acquired hardware manufacturer Motorola Mobility LLC in August 2011, they’ve made clear their intentions to loosen Samsung and Apple Inc.’s (AAPL) stranglehold on the American smartphone market. Those two companies between them control 62 percent of the US market, while Motorola holds a relatively paltry 7.8 percent.

But that could soon change. At an event in New York on August 1 Google will unveil the Moto X, the first smartphone developed solely by Google. And it could be Google’s last chance to finally become a major player in the smartphone game.     

While the Moto X is the first Google-directed phone, it’s not the first product released by Mobility under Google’s tenure. Mobility has already released the Atrix 4G and Droid RAZR phones and the Motorola Xoom tablet since August 2011. But the products haven’t done especially well, and embarrassingly lagged behind other brands utilizing Google’s Android operating system.

Motorola has simply lacked a product that makes a bold enough statement to pull customers away from Apple and Samsung. With Google now at the helm, they’re hoping they can change that.

Google could use another revenue stream. While the tech giant is still the unquestioned leader in search and the largest internet company on the planet, they still aren’t immune to disappointing quarters, as with the second quarter of 2013 that saw them miss analyst expectations.

Prior to the Google acquisition, Mobility had lost money five straight quarters, including a $342 million loss in Q2 2013. To pull Mobility out of their spiral, the Moto X will need to make a big splash.

Google has been largely secretive about what the product will be like. All that is know for sure is that it will be manufactured in the US, will have a highly customizable appearance, and a camera that can be activated with the flick of the wrist.

Google is up  1.61 percent to hit $901.77 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Spotlight

BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Events

EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more

Research

MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…